In this study, we concluded that low tumor purity in the CCL4 high groups might induce immunosuppressive TME, which contributes to antitumor immunity inhibition, activated immune checkpoint accumulation and a poor prognosis. The gene discussed is CCL4; the disease is neoplasm.